Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 26, 2019

SELL
$15.0 - $19.62 $77,145 - $100,905
-5,143 Closed
0 $0
Q3 2017

Oct 05, 2017

BUY
$19.76 - $24.9 $101,625 - $128,060
5,143
5,143 $111,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $529M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Washington Trust Bank Portfolio

Follow Washington Trust Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Washington Trust Bank, based on Form 13F filings with the SEC.

News

Stay updated on Washington Trust Bank with notifications on news.